SEVEN EIGHT CAPITAL, LP – Alnylam Pharmaceuticals, Inc. Transaction History
SEVEN EIGHT CAPITAL, LP portfolio value:
$985,000
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 4.92K shares | 985K | $200.16 | 4.92K |
Q2 2022 | share | Decrease | -100.00% | -1.76K shares | -288K | $145.85 | 0 |
Q1 2022 | share | Increase | 0.00% | 1.76K shares | 288K | $163.29 | 1.76K |
Q4 2019 | share | Decrease | -100.00% | -6.68K shares | -538K | $115.17 | 0 |
Q3 2019 | share | Increase | 0.00% | 6.68K shares | 538K | $80.42 | 6.68K |
Q3 2018 | share | Decrease | -100.00% | -10.48K shares | -1.03M | $87.52 | 0 |
Q2 2018 | share | Increase | 0.00% | 10.48K shares | 1.03M | $98.49 | 10.48K |
Q4 2017 | share | Decrease | -100.00% | -21.58K shares | -2.53M | $127.05 | 0 |
Q3 2017 | share | Increase | 0.00% | 21.58K shares | 2.53M | $117.49 | 21.58K |
Q2 2016 | share | Decrease | -100.00% | -2.7K shares | -169K | $55.49 | 0 |
Q1 2016 | share | Increase | +200.00% | 1.8K shares | 84K | $62.77 | 2.7K |